The Online Investor
Healthcare M&A image Healthcare M&A » By The Online Investor Staff, updated Fri., Dec. 6, 8:44 PM Recent mergers and acquisitions in the Healthcare M&A category.

Slide #4. Akorn, Inc. VersaPharm

Acquirer: Akorn, Inc. (NASDAQ:AKRX)
Acquiree: VersaPharm
Details: Akorn, Inc. (NASDAQ:AKRX) today announced that it has entered into a definitive agreement to acquire VPI Holdings Corp., the parent company of VersaPharm Incorporated, for $440 million in cash.

Akorn is a generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, branded as well as private-label over-the-counter consumer health products and animal health pharmaceuticals. Co.'s segments include: Prescription Pharmaceuticals, which primarily consists of generic and branded prescription pharmaceuticals in a variety of dosage forms including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals, nasal sprays and otics; and Consumer Health, which primarily consists of branded and private-label over-the-counter products and animal health products dispensed by veterinary personnel.

AKRX SEC Filing Email Alerts Service


Open the AKRX Page at The Online Investor »

Company Name: 
Akorn Inc
Website: 
www.akorn.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding AKRX: 
35
Total Market Value Held by ETFs: 
$72.87M
Total Market Capitalization: 
$487.00M
% of Market Cap. Held by ETFs: 
14.96%
 

Open the AKRX Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Hold (2.40 out of 4)
13rd percentile
(ranked lower than approx. 87% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Healthcare M&A - Slide 4 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2019, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.